Lorcaserin (APD-356, Belviq,[5][6], Lorqess[7][8]) je lek protiv gojaznosti. On ima serotonergička svojstva i deluje kao anoreksik. FDA nije odobrila njegovu primenu 2010, zbog zabrinutosti za bezbednost i efikasnost leka.[9] [10]
Lorkaserin
|
|
| (IUPAC) ime
|
| (1R)-8-hloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazepin
|
| Klinički podaci
|
| Robne marke
|
Belviq
|
| Identifikatori
|
| CAS broj
|
846589-98-8
|
| ATC kod
|
nije dodeljen
|
| PubChem[1][2]
|
11658860
|
| ChemSpider[3]
|
9833595
|
| UNII
|
637E494O0Z  Y
|
| ChEMBL[4]
|
CHEMBL360328 Y
|
| Hemijski podaci
|
| Formula
|
C11H14ClN
|
| Mol. masa
|
195,688 g/mol
|
| SMILES
|
eMolekuli & PubHem
|
| InChI |
|---|
InChI=1S/C11H14ClN/c1-8-7-13-5-4-9-2-3-10(12)6-11(8)9/h2-3,6,8,13H,4-5,7H2,1H3/t8-/m0/s1 Y
Key: XTTZERNUQAFMOF-QMMMGPOBSA-N Y |
|
| Farmakoinformacioni podaci
|
| Licenca
|
US FDA:link
|
| Trudnoća
|
X(US)
|
| Pravni status
|
℞-only (SAD)
|
| Način primene
|
Oralno
|
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
- ↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
- ↑ „FDA approves Arena obesity drug; first in 13 years”. Reuters. 27. 6. 2012.. Arhivirano iz originala na datum 2014-07-27. Pristupljeno 2014-04-05.
- ↑ „Belviq”. Trademarkia. 23 Jun 2011. Pristupljeno 27. 6. 2012.
- ↑ „Lorqess”. EvaluatePharma. 7. 9. 2010.. Pristupljeno 13. 9. 2010.
- ↑ „Lorqess”. Trademarkia. 25. 3. 2010.. Pristupljeno 13. 9. 2010.
- ↑ Andrew Pollack (16. 9. 2010.). „F.D.A. Panel Urges Denial of Diet Drug”. New York Times.
- ↑ „FDA Issues Complete Response Letter for Lorcaserin New Drug Application”. 23. 10. 2010..
Spoljašnje veze
uredi
